Prezzo di chiusura
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
1.171 INR | +1,01% |
|
+6,69% | -26,92% |
Attività
Numero di dipendenti: 608
Vendite per attività
INR in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Phase Transfer Catalysts
34,0
%
| 980 | 22,7 % | 1 432 | 34,0 % | +46,09% |
Pharmaceutical and Agrochemical Intermediates and Other Specialty Chemicals
31,7
%
| 1 028 | 23,8 % | 1 335 | 31,7 % | +29,93% |
Structure Directing Agents
30,3
%
| 2 248 | 52,1 % | 1 276 | 30,3 % | -43,23% |
Electrolyte Salts
3,9
%
| 57 | 1,3 % | 165 | 3,9 % | +190,92% |
Vendite per regione
INR in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
International
72,3
%
| 3 405 | 78,9 % | 3 042 | 72,3 % | -10,64% |
India
27,7
%
| 908 | 21,1 % | 1 167 | 27,7 % | +28,44% |
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Chief Executive Officer | 51 | 12/06/96 | |
Ashok Bothra
DFI | Director of Finance/CFO | - | 03/12/21 |
Chief Administrative Officer | - | 21/11/15 | |
Chief Operating Officer | - | 12/10/17 | |
Ajay Singh Rawat
CTO | Chief Tech/Sci/R&D Officer | - | 05/07/19 |
Compliance Officer | - | 17/01/22 | |
Rakesh Poonia
PRN | Corporate Officer/Principal | - | 17/11/06 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Director/Board Member | 64 | 27/02/21 | |
Chief Executive Officer | 51 | 12/06/96 | |
Director/Board Member | 52 | 12/06/96 | |
Director/Board Member | 50 | 12/06/96 | |
Director/Board Member | 71 | 27/02/21 | |
Director/Board Member | 52 | 27/02/21 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 23 392 055 | 6 545 097 ( 27,98 %) | 0 | 27,98 % |
Coordinate società
Tatva Chintan Pharma Chem Ltd.
GIDC Estate Plot No 502/17
393002, Ankleshwar
+91 75 7484 8533
http://www.tatvachintan.com![Indirizzo Tatva Chintan Pharma Chem Limited(TATVA)](https://cdn.zonebourse.com/static/address/125324750.png)
Vendite per attività
Vendite per regione
![Consenso](/images/consensus_flch.gif)
Revisioni EPS
Variaz. 1 gen. | Capi. | |
---|---|---|
-26,92% | 325 Mln | |
+19,51% | 67,35 Mrd | |
-5,30% | 46,44 Mrd | |
+22,19% | 44,28 Mrd | |
+36,70% | 29,14 Mrd | |
+11,89% | 19,48 Mrd | |
+14,26% | 17,17 Mrd | |
-25,77% | 15,04 Mrd | |
-15,32% | 14,72 Mrd | |
-31,40% | 12,07 Mrd |
- Borsa valori
- Azioni
- Azione TATVA
- Società Tatva Chintan Pharma Chem Limited